Newborns in a handful of US cities will soon be part of an effort to study whether whole-genome sequencing should be a regular component of healthcare for infants. Four pilot projects recently received $25 million in funding from the US National Institutes of Health to test sequencing as a part of newborn screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.